Clinical Trial Update: A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris [Phase 3]

View source ↗

Summary

Phase 3 trial comparing tazarotene 0.1% cream to a comparator and placebo in acne vulgaris completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Tazorac (tazarotene) cream, 0.1% (tazarotene)

Snippet

Sponsor: Fougera Pharmaceuticals Inc. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2018-08-17